Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation

AC inhibition, a potential radiosensitizer

Ayman E.M. Mahdy, Joseph C. Cheng, Jun Li, Saeed Elojeimy, William D. Meacham, Lorianne S. Turner, Aiping Bai, Christopher R. Gault, Alex S. McPherson, Nicole Garcia, Thomas H. Beckham, Antonio Saad, Alicja Bielawska, Jacek Bielawski, Yusuf A. Hannun, Thomas E. Keane, Mohhammed I. Taha, Hisham M. Hammouda, James S. Norris, Xiang Liu

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy. The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC). Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate. By genetically downregulating AC with small interfering RNA (siRNA), we observed radiosensitization of cells using clonogenic and cytotoxicity assays. Conversely, AC overexpression further decreased sensitivity to radiation. We also observed that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls. Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance. Finally, utilization of the small molecule AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth. These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC that is, in part, mediated by application of the therapy itself. An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.

Original languageEnglish (US)
Pages (from-to)430-438
Number of pages9
JournalMolecular Therapy
Volume17
Issue number3
DOIs
StatePublished - Mar 11 2009
Externally publishedYes

Fingerprint

Acid Ceramidase
Prostatic Neoplasms
Up-Regulation
Radiation
Radiation Effects
Neoplasms
Radiotherapy
Caspase 7
Sphingosine
Ceramides
Radiation Tolerance
Paclitaxel
Heterografts
Caspase 3
Small Interfering RNA
Prostate
Therapeutics
Down-Regulation
Drug Therapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

Mahdy, A. E. M., Cheng, J. C., Li, J., Elojeimy, S., Meacham, W. D., Turner, L. S., ... Liu, X. (2009). Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer. Molecular Therapy, 17(3), 430-438. https://doi.org/10.1038/mt.2008.281

Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation : AC inhibition, a potential radiosensitizer. / Mahdy, Ayman E.M.; Cheng, Joseph C.; Li, Jun; Elojeimy, Saeed; Meacham, William D.; Turner, Lorianne S.; Bai, Aiping; Gault, Christopher R.; McPherson, Alex S.; Garcia, Nicole; Beckham, Thomas H.; Saad, Antonio; Bielawska, Alicja; Bielawski, Jacek; Hannun, Yusuf A.; Keane, Thomas E.; Taha, Mohhammed I.; Hammouda, Hisham M.; Norris, James S.; Liu, Xiang.

In: Molecular Therapy, Vol. 17, No. 3, 11.03.2009, p. 430-438.

Research output: Contribution to journalArticle

Mahdy, AEM, Cheng, JC, Li, J, Elojeimy, S, Meacham, WD, Turner, LS, Bai, A, Gault, CR, McPherson, AS, Garcia, N, Beckham, TH, Saad, A, Bielawska, A, Bielawski, J, Hannun, YA, Keane, TE, Taha, MI, Hammouda, HM, Norris, JS & Liu, X 2009, 'Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer', Molecular Therapy, vol. 17, no. 3, pp. 430-438. https://doi.org/10.1038/mt.2008.281
Mahdy, Ayman E.M. ; Cheng, Joseph C. ; Li, Jun ; Elojeimy, Saeed ; Meacham, William D. ; Turner, Lorianne S. ; Bai, Aiping ; Gault, Christopher R. ; McPherson, Alex S. ; Garcia, Nicole ; Beckham, Thomas H. ; Saad, Antonio ; Bielawska, Alicja ; Bielawski, Jacek ; Hannun, Yusuf A. ; Keane, Thomas E. ; Taha, Mohhammed I. ; Hammouda, Hisham M. ; Norris, James S. ; Liu, Xiang. / Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation : AC inhibition, a potential radiosensitizer. In: Molecular Therapy. 2009 ; Vol. 17, No. 3. pp. 430-438.
@article{d5a6ad6f81674881b4ee77478056176d,
title = "Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer",
abstract = "Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy. The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC). Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate. By genetically downregulating AC with small interfering RNA (siRNA), we observed radiosensitization of cells using clonogenic and cytotoxicity assays. Conversely, AC overexpression further decreased sensitivity to radiation. We also observed that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls. Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance. Finally, utilization of the small molecule AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth. These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC that is, in part, mediated by application of the therapy itself. An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.",
author = "Mahdy, {Ayman E.M.} and Cheng, {Joseph C.} and Jun Li and Saeed Elojeimy and Meacham, {William D.} and Turner, {Lorianne S.} and Aiping Bai and Gault, {Christopher R.} and McPherson, {Alex S.} and Nicole Garcia and Beckham, {Thomas H.} and Antonio Saad and Alicja Bielawska and Jacek Bielawski and Hannun, {Yusuf A.} and Keane, {Thomas E.} and Taha, {Mohhammed I.} and Hammouda, {Hisham M.} and Norris, {James S.} and Xiang Liu",
year = "2009",
month = "3",
day = "11",
doi = "10.1038/mt.2008.281",
language = "English (US)",
volume = "17",
pages = "430--438",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation

T2 - AC inhibition, a potential radiosensitizer

AU - Mahdy, Ayman E.M.

AU - Cheng, Joseph C.

AU - Li, Jun

AU - Elojeimy, Saeed

AU - Meacham, William D.

AU - Turner, Lorianne S.

AU - Bai, Aiping

AU - Gault, Christopher R.

AU - McPherson, Alex S.

AU - Garcia, Nicole

AU - Beckham, Thomas H.

AU - Saad, Antonio

AU - Bielawska, Alicja

AU - Bielawski, Jacek

AU - Hannun, Yusuf A.

AU - Keane, Thomas E.

AU - Taha, Mohhammed I.

AU - Hammouda, Hisham M.

AU - Norris, James S.

AU - Liu, Xiang

PY - 2009/3/11

Y1 - 2009/3/11

N2 - Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy. The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC). Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate. By genetically downregulating AC with small interfering RNA (siRNA), we observed radiosensitization of cells using clonogenic and cytotoxicity assays. Conversely, AC overexpression further decreased sensitivity to radiation. We also observed that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls. Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance. Finally, utilization of the small molecule AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth. These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC that is, in part, mediated by application of the therapy itself. An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.

AB - Radiation resistance in a subset of prostate tumors remains a challenge to prostate cancer radiotherapy. The current study on the effects of radiation on prostate cancer cells reveals that radiation programs an unpredicted resistance mechanism by upregulating acid ceramidase (AC). Irradiated cells demonstrated limited changes of ceramide levels while elevating levels of sphingosine and sphingosine-1-phosphate. By genetically downregulating AC with small interfering RNA (siRNA), we observed radiosensitization of cells using clonogenic and cytotoxicity assays. Conversely, AC overexpression further decreased sensitivity to radiation. We also observed that radiation-induced AC upregulation was sufficient to create cross-resistance to chemotherapy as demonstrated by decreased sensitivity to Taxol and C6 ceramide compared to controls. Lower levels of caspase 3/7 activity were detected in cells pretreated with radiation, also indicating increased resistance. Finally, utilization of the small molecule AC inhibitor, LCL385, sensitized PPC-1 cells to radiation and significantly decreased tumor xenograft growth. These data suggest a new mechanism of cancer cell resistance to radiation, through upregulation of AC that is, in part, mediated by application of the therapy itself. An improved understanding of radiotherapy and the application of combination therapy achieved in this study offer new opportunities for the modulation of radiation effects in the treatment of cancer.

UR - http://www.scopus.com/inward/record.url?scp=61649091570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649091570&partnerID=8YFLogxK

U2 - 10.1038/mt.2008.281

DO - 10.1038/mt.2008.281

M3 - Article

VL - 17

SP - 430

EP - 438

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 3

ER -